Psyched Wellness (TSE:PSYC)
:PSYC
Want to see TSE:PSYC full AI Analyst Report?
PSYC Stock Chart & Stats
C$0.02
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.02
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.03
Previous CloseN/A
Volume20.00K
Average Volume (3M)81.03K
Market Cap
C$4.33M
Enterprise ValueC$2.08M
Total Cash (Recent Filing)C$751.53K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.07
Next Earnings
May 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding288,816,830
10 Day Avg. Volume36,477
30 Day Avg. Volume81,030
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)1.86
Price to Sales (P/S)12.22
P/FCF Ratio-1.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Product-level MarginsPositive gross profit indicates the company's Amanita muscaria product formulations generate unit economics that cover direct costs. Sustainable product margins give management a pathway to profitability as volumes scale, enabling reinvestment in distribution and marketing without destroying per-unit economics.
No Reported DebtHaving no reported debt materially reduces financial fragility: lower fixed obligations and interest burden improve flexibility when raising capital or navigating downturns. This steadies the capital structure and preserves operating cash for growth initiatives rather than servicing lenders.
Early Commercialization TractionMoving from near-zero sales to meaningful revenue demonstrates initial product-market fit and execution capability in distribution and DTC channels. This early commercialization offers a foundation to expand reach and improve unit economics if management sustains distribution growth and repeat purchase rates.
Bears Say
Large Operating LossesA net loss of roughly $5.0M on under $0.5M revenue reflects a cost base disproportionately large versus current sales. Persisting at this scale without rapid revenue expansion or structural cost reduction threatens long-term viability and will pressure management to pursue dilutive financing or major restructuring.
Worsening Cash BurnDeepening negative free cash flow shows the business cannot self-fund operations or growth and is consuming cash faster over time. Continued cash burn raises the probability of repeated external funding, increasing dilution risk and constraining long-term investments in marketing, supply chain, or product development.
Equity Erosion / Financing RiskA rapid decline in equity signals that accumulated losses have materially eroded shareholder capital and the company's balance sheet cushion. This heightens the need for fresh capital, makes future financing more dilutive or costly, and reduces the firm's ability to absorb operational setbacks while pursuing long-term growth.
Psyched Wellness News
PSYC FAQ
What was Psyched Wellness’s price range in the past 12 months?
Psyched Wellness lowest stock price was C$0.01 and its highest was C$0.03 in the past 12 months.
What is Psyched Wellness’s market cap?
Psyched Wellness’s market cap is C$4.33M.
When is Psyched Wellness’s upcoming earnings report date?
Psyched Wellness’s upcoming earnings report date is May 04, 2026 which is in 2 days.
How were Psyched Wellness’s earnings last quarter?
Psyched Wellness released its earnings results on Mar 26, 2026. The company reported -C$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.005.
Is Psyched Wellness overvalued?
According to Wall Street analysts Psyched Wellness’s price is currently Overvalued.
Does Psyched Wellness pay dividends?
Psyched Wellness does not currently pay dividends.
What is Psyched Wellness’s EPS estimate?
Psyched Wellness’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Psyched Wellness have?
Psyched Wellness has 288,816,830 shares outstanding.
What happened to Psyched Wellness’s price movement after its last earnings report?
Psyched Wellness reported an EPS of -C$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 50%.
Which hedge fund is a major shareholder of Psyched Wellness?
Currently, no hedge funds are holding shares in TSE:PSYC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Psyched Wellness
Psyched Wellness Ltd., a health supplements company, engages in the production and distribution of artisanal, medicinal mushrooms and associated consumer packaged goods. It offers Amanita Muscaria Tincture, which soothes the body, tackles physical distress, reduce stress, ease muscular tension, and promotes restorative sleep. The company was formerly known as Duncan Park Holdings Corporation and changed its name to Psyched Wellness Ltd. in July 2020. Psyched Wellness Ltd. was incorporated in 2019 and is based in Toronto, Canada.
Technical Analysis
Blender Bites
―
Jamieson Wellness Inc
―
Happy Belly Food Group
―
Happy Supplements Inc.
―
Cult Food Science Corp.
―
Options Prices
Currently, No data available
---